Clinical characteristics in urolithiasis formation according to body mass index

Takeuchi,Hisashi; Aoyagi,Teiichiro

doi:10.3892/br.2019.1220

Clinical characteristics in urolithiasis formation according to body mass index

Authors:
- Hisashi Takeuchi
- Teiichiro Aoyagi
View Affiliations

Affiliations: Department of Urology, Tokyo Medical University Ibaraki Medical Center, Ibaraki 300‑0395, Japan
Published online on: June 7, 2019 https://doi.org/10.3892/br.2019.1220
Pages: 38-42

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Although urolithiasis is considered to be strongly associated with lifestyle habits, there are numerous cases in which urolithiasis develops despite a non‑obese body type or healthy lifestyle habits. However, in clinical practice, the diet therapy and lifestyle changes instructed for the prevention of recurrence of urolithiasis are almost identical in numerous cases. Therefore, the present study examined the effect of body mass index (BMI) on urolithiasis and its surrounding environment in patients, by analyzing the number of normal‑ and high‑BMI (healthy and overweight) patients with urolithiasis. The present study analyzed 63 patients with urolithiasis for whom height and weight were measured at our hospital (Tokyo Medical University Ibaraki Medical Center). BMI <25 represents healthy body types and BMI ≥25 BMI defines overweight body types. Thus, patients were then grouped by BMI‑defined body type using a threshold value of 25 accordingly. It was observed that a higher percentage of males were obese compared with females. Upon comparing the normal‑ and high‑BMI groups, no significant difference was observed in uric acid level, urine pH or calculus number between the two groups. Liver computed tomography (CT) values were significantly lower in the high‑BMI group compared with the normal‑BMI group. There was no significant correlation between calculus size counts and BMI. However, a significant negative correlation was observed between BMI and the liver CT value. These results suggest that liver CT values correlated negatively with BMI, but the data indicates that other mechanisms unassociated with a fatty liver may be involved in urolithiasis in non‑obese patients. The results of the present study suggest that physicians should consider the mechanism involved in preventing the recurrence of urolithiasis.

View Figures

View References

1	Asper R: Epidemiology and socioeconomic aspects of urolithiasis. Urol Res. 12:1–5. 1984.PubMed/NCBI
2	Yasui T, Iguchi M, Suzuki S and Kohri K: Prevalence and epidemiological characteristics of urolithiasis in Japan: National trends between 1965 and 2005. Urology. 71:209–213. 2008.PubMed/NCBI View Article : Google Scholar
3	Pak CY: Kidney stones. Lancet. 351:1797–1801. 1998.PubMed/NCBI View Article : Google Scholar
4	Breslau NA, Brinkley L, Hill KD and Pak CY: Relationship of animal protein-rich diet to kidney stone formation and calcium metabolism. J Clin Endocrinol Metab. 66:140–146. 1988.PubMed/NCBI View Article : Google Scholar
5	Curhan GC, Willett WC, Rimm EB and Stampfer MJ: A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med. 328:833–838. 1993.PubMed/NCBI View Article : Google Scholar
6	Sakhaee K: Nephrolithiasis as a systemic disorder. Curr Opin Nephrol Hypertens. 17:304–309. 2008.PubMed/NCBI View Article : Google Scholar
7	Sakhaee K and Maalouf NM: Metabolic syndrome and uric acid nephrolithiasis. Semin Nephrol. 28:174–180. 2008.PubMed/NCBI View Article : Google Scholar
8	Cameron MA, Maalouf NM, Adams-Huet B, Moe OW and Sakhaee K: Urine composition in type 2 diabetes: Predisposition to uric acid nephrolithiasis. J Am Soc Nephrol. 17:1422–1428. 2006.PubMed/NCBI View Article : Google Scholar
9	Abate N, Chandalia M, Cab-Chan AV Jr, Moe OW and Sakhaee K: The metabolic syndrome and uric acid nephrolithiasis: Novel features of renal manifestation of insulin resistance. Kidney Int. 65:386–392. 2004.PubMed/NCBI View Article : Google Scholar
10	Maalouf NM, Cameron MA, Moe OW, Adams-Huet B and Sakhaee K: Low urine pH: A novel feature of the metabolic syndrome. Clin J Am Soc Nephrol. 2:883–888. 2007.PubMed/NCBI View Article : Google Scholar
11	WHO Expert Consultation: Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363: 157-163, 2004.
12	Bydder GM, Kreel L, Chapman RW, Harry D, Sherlock S and Bassan L: Accuracy of computed tomography in diagrosis of fatty liver. Br Med J. 281(1042)1980.PubMed/NCBI View Article : Google Scholar
13	Kan H, Kimura Y, Hyogo H, Fukuhara T, Fujino H, Naeshiro N, Honda Y, Kawaoka T, Tsuge M, Chayama K, et al: Non-invasive assessment of liver steatosis in non-alcoholic fatty liver disease. Hepatol Res. 44:E420–E427. 2014.PubMed/NCBI View Article : Google Scholar
14	Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, McCullough AJ, Natale S, Forlani G and Melchionda N: Nonalcoholic fatty liver disease: A feature of the metabolic syndrome. Diabetes. 50:1844–1850. 2001.PubMed/NCBI View Article : Google Scholar
15	Maruhama Y, Ohneda A, Tadaki H, Ohtsuki M and Yanbe A: Hepatic steatosis and the elevated plasma insulin level in patients with endogenous hypertriglyceridemia. Metabolism. 24:653–664. 1975.PubMed/NCBI View Article : Google Scholar
16	Targher G, Bertolini L, Rodella S, Tessari R, Zenari L, Lippi G and Arcaro G: Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular event in type 2 diabetic patients. Diabetes Care. 30:2119–2121. 2007.PubMed/NCBI View Article : Google Scholar
17	Taylor EN and Curhan GC: Fructose consumption and the risk of kidney stones. Kidney Int. 73:207–212. 2008.PubMed/NCBI View Article : Google Scholar
18	Murayama T, Sakai N, Takano T and Yamada T: Role of the diurnal variation of urinary pH and urinary calcium in urolithiasis: A study in outpatients. Int J Urol. 8:525–532. 2001.PubMed/NCBI View Article : Google Scholar
19	Sakai N: Recent issues in urolithiasis. J Analytical Bio Sci. 32:215–219. 2009.
20	Taylor EN, Stampfer MJ and Curhan GC: Obesity, weight gain, and the risk of kidney stones. JAMA. 293:455–462. 2005.PubMed/NCBI View Article : Google Scholar
21	Ando R, Suzuki S, Nagaya T, Yamada T, Okada A, Yasui T, Tozawa K, Tokudome S and Kohri K: Impact of insulin resistance, insulin and adiponectin on kidney stones in the Japanese population. Int J Urol. 18:131–138. 2011.PubMed/NCBI View Article : Google Scholar
22	Strohmaier WL, Witte B and Nelde HJ: Influence of nifedipine on stone formation and renal function in chlesterol-induced nephrolithiasis in rats. Urol Int. 52:87–92. 1994.PubMed/NCBI View Article : Google Scholar
23	Ando R, Nagaya T, Suzuki S, Takahashi H, Kawai M, Okada A, Yasui T, Kubota Y, Umemoto Y, Tozawa K and Kohri K: Kidney stone formation is positively associated with conventional risk factors for coronary heart disease in Japanese men. J Urol. 189:1340–1346. 2013.PubMed/NCBI View Article : Google Scholar
24	Okada A, Yasui T, Hamamoto S, Hirose M, Kubota Y, Itoh Y, Tozawa K, Hayashi Y and Kohri K: Genome-wide analysis of genes related to kidney stone formation and elimination in the calcium oxalate nephrolithiasis model mouse: Detection of stone-preventive factors and involvement of macrophage activity. J Bone Miner Res. 24:908–924. 2009.PubMed/NCBI View Article : Google Scholar
25	Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A and Locati M: The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 25:677–686. 2004.PubMed/NCBI View Article : Google Scholar
26	Zhang MZ, Yao B, Yang S, Jiang L, Wang S, Fan X, Yin H, Wong K, Miyazawa T, Chen J, et al: CSF-1 signaling mediates recovery from acute kidney injury. J Clin Invest. 122:4519–4532. 2012.PubMed/NCBI View Article : Google Scholar
27	Lee S, Huen S, Nishio H, Nishio S, Lee HK, Choi BS, Ruhrberg C and Cantley LG: Distinct macrophage phenotypes contribute to kidney injury and repair. J Am Soc Nephrol. 22:317–326. 2011.PubMed/NCBI View Article : Google Scholar
28	Takeuchi H, Tanaka M, Tanaka A, Tsunemi A and Yamamoto H: Predominance of M2-polarized macrophages in bladder cancer affects angiogenesis, tumor grade and invasiveness. Oncol Lett. 11:3403–3408. 2016.PubMed/NCBI View Article : Google Scholar
29	Ichikawa J, Okada A, Taguchi K, Fujii Y, Zuo L, Niimi K, Hamamoto S, Kubota Y, Umemoto Y, Kohri K, et al: Increased crystal-cell interaction in vitro under co-culture of renal tubular cells and adipocytes by in vitro co-culture paracrine systems simulating metabolic syndrome. Urolithiasis. 42:17–28. 2014.PubMed/NCBI View Article : Google Scholar
30	Taguchi K, Okada A, Kitamura H, Yasui T, Naiki T, Hamamoto S, Ando R, Mizuno K, Kawai N, Kohri K, et al: Colony-stimulating factor-1 signaling suppresses renal crystal formation. J Am Soc Nephrol. 25:1680–1697. 2014.PubMed/NCBI View Article : Google Scholar